AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,89 USD
arrow_downward
-0,86%(-0,26) 1D
29,89 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 17-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
30,09 USD
High
30,38 USD
Low
28,94 USD
Mkt. cap
1,79 млд
Avg. vol.
1,23 млн
Volume
1,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
30,09 USD
High
30,38 USD
Low
28,94 USD
Mkt. cap
1,79 млд
Avg. vol.
1,23 млн
Volume
1,00
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
FOREX.com
·
55 мүнөт мурун
S&P 500 Quietly Shrugs Off the Bitcoin and Silver Selloff
Reuters
·
59 мүнөт мурун
UBS sees S&P 500 at 8,200 by end-2027 on earnings strength, resilient economy
BeInCrypto
·
2 саат мурун
How Deep Do S&P 500 Corrections Usually Go? Where 2026’s Drop Ranks
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc